Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
Abstract Huntington’s disease is characterized by a complex and heterogeneous pathogenic profile. Studies have shown that disturbance in lipid homeostasis may represent a critical determinant in the progression of several neurodegenerative disorders. The recognition of perturbed lipid metabolism is...
Guardado en:
Autores principales: | Alba Di Pardo, Enrico Amico, Abdul Basit, Andrea Armirotti, Piyush Joshi, M. Diana Neely, Romina Vuono, Salvatore Castaldo, Anna F. Digilio, Francesco Scalabrì, Giuseppe Pepe, Francesca Elifani, Michele Madonna, Se Kyoo Jeong, Bu-Mahn Park, Maurizio D’Esposito, Aaron B. Bowman, Roger A. Barker, Vittorio Maglione |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf0f9516edd7471585e05c6cc1d03c10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deep white matter in Huntington's disease.
por: Owen Phillips, et al.
Publicado: (2014) -
KRAS mutation: from undruggable to druggable in cancer
por: Lamei Huang, et al.
Publicado: (2021) -
The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries.
por: Mihwa Lim, et al.
Publicado: (2012) -
Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype.
por: Lukasz Japtok, et al.
Publicado: (2012) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Hamidreza Aboulkheyr Es, et al.
Publicado: (2021)